Erika Rimondi

1.7k total citations
65 papers, 1.3k citations indexed

About

Erika Rimondi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Erika Rimondi has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 25 papers in Oncology and 11 papers in Immunology. Recurrent topics in Erika Rimondi's work include Cell death mechanisms and regulation (11 papers), Bone health and treatments (9 papers) and Bone Metabolism and Diseases (9 papers). Erika Rimondi is often cited by papers focused on Cell death mechanisms and regulation (11 papers), Bone health and treatments (9 papers) and Bone Metabolism and Diseases (9 papers). Erika Rimondi collaborates with scholars based in Italy, United States and United Kingdom. Erika Rimondi's co-authors include Giorgio Zauli, Paola Secchiero, E. Melloni, Claudio Celeghini, Federica Corallini, Daniela Milani, Silvano Capitani, Carlotta Zerbinati, Maria Grazia di Iasio and Annalisa Marcuzzi and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Erika Rimondi

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Rimondi Italy 20 830 356 310 269 109 65 1.3k
Tatyana Vlaykova Bulgaria 21 651 0.8× 516 1.4× 348 1.1× 297 1.1× 83 0.8× 92 1.5k
Orr Sharpe United States 19 497 0.6× 182 0.5× 354 1.1× 219 0.8× 83 0.8× 25 1.5k
Yuhua Li China 24 861 1.0× 641 1.8× 244 0.8× 367 1.4× 86 0.8× 88 1.7k
Wenting Liu China 18 512 0.6× 212 0.6× 264 0.9× 210 0.8× 231 2.1× 58 1.3k
Ali Moshfegh Sweden 21 755 0.9× 524 1.5× 304 1.0× 226 0.8× 85 0.8× 60 1.4k
Fei Cao China 20 600 0.7× 333 0.9× 248 0.8× 306 1.1× 82 0.8× 77 1.4k
Shaoyu Yan United States 25 910 1.1× 595 1.7× 166 0.5× 326 1.2× 115 1.1× 39 1.9k
Xiaomei Zhang China 16 706 0.9× 768 2.2× 631 2.0× 349 1.3× 123 1.1× 36 1.9k
Hannes Neuwirt Austria 23 787 0.9× 548 1.5× 313 1.0× 418 1.6× 80 0.7× 62 1.8k
Zhengtang Chen China 24 835 1.0× 813 2.3× 345 1.1× 396 1.5× 91 0.8× 49 1.6k

Countries citing papers authored by Erika Rimondi

Since Specialization
Citations

This map shows the geographic impact of Erika Rimondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Rimondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Rimondi more than expected).

Fields of papers citing papers by Erika Rimondi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Rimondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Rimondi. The network helps show where Erika Rimondi may publish in the future.

Co-authorship network of co-authors of Erika Rimondi

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Rimondi. A scholar is included among the top collaborators of Erika Rimondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Rimondi. Erika Rimondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Secchiero, Paola, Erika Rimondi, Annalisa Marcuzzi, et al.. (2024). Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota. International Journal of Molecular Sciences. 25(15). 8098–8098. 7 indexed citations
2.
Caruso, Lorenzo, Erika Rimondi, Giorgio Zauli, et al.. (2024). Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions. International Journal of Molecular Sciences. 25(4). 2124–2124. 4 indexed citations
3.
Maximova, Natalia, Alessandra Maestro, Egidio Barbi, et al.. (2023). Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study. Cancers. 15(14). 3605–3605. 2 indexed citations
4.
Marcuzzi, Annalisa, et al.. (2023). Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients. Life Science Alliance. 6(5). e202201786–e202201786. 4 indexed citations
5.
Marcuzzi, Annalisa, et al.. (2023). Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations. International Journal of Molecular Sciences. 24(4). 3739–3739. 56 indexed citations
6.
Melloni, E., Silvia Grassilli, Arianna Romani, et al.. (2023). Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model. Nutrients. 15(7). 1727–1727. 1 indexed citations
7.
Melloni, E., Elena Marchesi, Fabio Casciano, et al.. (2022). Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids. Molecules. 27(2). 471–471. 12 indexed citations
8.
Marcuzzi, Annalisa, Erika Rimondi, E. Melloni, et al.. (2022). New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib. Pharmaceuticals. 15(3). 374–374. 12 indexed citations
9.
Pisanti, Simona, Erika Rimondi, E. Melloni, et al.. (2022). Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation. International Journal of Environmental Research and Public Health. 19(15). 9061–9061. 7 indexed citations
10.
Marcuzzi, Annalisa, E. Melloni, Giorgio Zauli, et al.. (2021). Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity. International Journal of Molecular Sciences. 22(20). 11241–11241. 31 indexed citations
11.
Rimondi, Erika, Erica Valencic, Alberto Tommasini, et al.. (2021). Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation. Biomolecules. 11(10). 1438–1438.
12.
Rimondi, Erika, E. Melloni, Arianna Romani, et al.. (2021). Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors. Current Oncology. 28(4). 2439–2451. 5 indexed citations
13.
Rimondi, Erika, Annalisa Marcuzzi, Fabio Casciano, et al.. (2020). Role of vitamin D in the pathogenesis of atheromatosis. Nutrition Metabolism and Cardiovascular Diseases. 31(1). 344–353. 6 indexed citations
14.
Bernardi, Stella, Rebecca Voltan, Erika Rimondi, et al.. (2019). TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?. Clinical Science. 133(10). 1145–1166. 23 indexed citations
15.
Zamboni, Paolo, Alessia Giaquinta, Erika Rimondi, et al.. (2018). A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment. Phlebology The Journal of Venous Disease. 34(5). 336–346. 2 indexed citations
16.
Zamboni, Paolo, Francesco Sisini, Massimo Pedriali, et al.. (2018). Venous compliance and clinical implications. SHILAP Revista de lepidopterología. 7(2). 18 indexed citations
17.
Fantinati, Anna, Sara Bianco, Alberto Cavazzini, et al.. (2017). Expeditious Synthesis and Biological Characterization of Enantio‐Enriched (‐)‐Nutlin‐3. ChemistrySelect. 2(27). 8504–8508. 5 indexed citations
18.
Voltan, Rebecca, Erika Rimondi, E. Melloni, et al.. (2016). Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1. Oncotarget. 7(14). 18965–18977. 26 indexed citations
19.
Secchiero, Paola, Erika Rimondi, Maria Grazia di Iasio, et al.. (2013). C-Reactive Protein Downregulates TRAIL Expression in Human Peripheral Monocytes via an Egr-1–Dependent Pathway. Clinical Cancer Research. 19(8). 1949–1959. 35 indexed citations
20.
Secchiero, Paola, Carlotta Zerbinati, Erika Rimondi, et al.. (2004). TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Cellular and Molecular Life Sciences. 61(15). 1965–1974. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatyana Vlaykova Breakdown of academic impact, for papers by Orr Sharpe Breakdown of academic impact, for papers by Yuhua Li Breakdown of academic impact, for papers by Wenting Liu Breakdown of academic impact, for papers by Ali Moshfegh Breakdown of academic impact, for papers by Fei Cao Breakdown of academic impact, for papers by Shaoyu Yan Breakdown of academic impact, for papers by Xiaomei Zhang Breakdown of academic impact, for papers by Hannes Neuwirt Breakdown of academic impact, for papers by Zhengtang Chen
Rankless by CCL
2026